Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventing Severe Anemia in Pregnant Women in Zanzibar
NCT00148629Phase 3Completed
- Sponsor
- Cornell University
- Start
- Apr 2004
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of thiamine + riboflavin + pyridoxine + niacin + cobalamin + ascorbic acid + tocopherol and mebendazole in anemia (2 arms), sponsored by Cornell University. Primary endpoints: Incidence of severe anemia (Hb < 7 g/dL) and Cure of severe anemia. Started Apr 2004; status: completed.
02
Drugs
thiamine + riboflavin + pyridoxine + niacin + cobalamin + ascorbic acid + tocopherolmebendazole
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00148629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00148629.